|
Index of reports
> Cases resulting in a serious event (741)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in a serious event.
Reports 1 - 25 of 741 Next >>
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrogen NOS
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 1997-04-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Climara
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 79.5 kg (174.8 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Estrace
Estradiol
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms Prophylaxis
Start date: 1989-01-01
Estrogens Esterified / Methyltestosterone
Premarin
Dosage: unspecified
Administration route: Oral
Start date: 1992-01-01
End date: 2004-01-01
Other drugs received by patient: Xanax
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-31
Patient: female, weighing 74.9 kg (164.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2002-03-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Endometrial Cancer Metastatic, Ovarian Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1982-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer, Lung Neoplasm Malignant, Myocardial Infarction, Cerebrovascular Accident
Suspect drug(s):
Estrogen NOS
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Systemic Lupus Erythematosus
Suspect drug(s):
Medroxyprogesterone Acetate
Premarin
Prempro
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 57.7 kg (126.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Premarin
Prempro
Dosage: not specified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in 75 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 75 year old female
Adverse reactions / side effects: Cerebrovascular Accident
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Pravastin (Pravastin); Prilosec; Benicar; Singulair
Adverse event in 63 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Transient Ischaemic Attack
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 58 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Premarin
Indication: Oestrogen Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 63 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-05-22
End date: 1998-03-11
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-03-01
End date: 1989-05-24
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 56 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Premarin
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 60 year old female
Adverse reactions / side effects: Endometrial Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Medroxyprogesterone
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 53 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Start date: 1987-01-01
End date: 1999-01-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1987-01-01
End date: 1999-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 53 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 48 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Page 1 Next >>
|
